Find effective medications for 'Cryptococcal Meningitis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

As a result of a large randomized, controlled trial (and experience during the first 15 years of the AIDS epidemic), standard guidelines for treatment of cryptococcal meningitis recommend 2 weeks of ...

Amphotericin B iv. 0.7–1 mg/kg q.d., plus flucytosine o.s. 25 mg/kg q.i.d. Fluconazole o.s./iv. 800–1200 mg q.d. Fluconazole o.s./iv. 400 mg q.d. Fluconazole o.s ...

A new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and has the potential to reduce the length and cost of hospital admissions, a ...

In most clinical centres in Africa, despite access to antiretroviral therapies, cases of HIV-associated cryptococcal meningitis (CM) are not decreasing owing to challenges with retention and adherence ...

For decades cryptococcal meningitis has flown under the radar, despite its high mortality rate, but this fungal brain infection is finally getting the attention it deserves with the launch of the ...

Cryptococcal meningitis is an infection of the meninges (membranes covering the spinal cord and brain), which is caused by the fungus Cryptococcus neoformans. This fungus is found in the environment ...

To the Editor: Beardsley et al. (Feb. 11 issue) 1 report on a randomized clinical trial in which a group of patients with human immunodeficiency virus (HIV)–associated cryptococcal meningitis received ...